PolyPeptide Group Management
Management criteria checks 2/4
PolyPeptide Group's CEO is Juan Gonzalez, appointed in Apr 2023, has a tenure of 1.75 years. total yearly compensation is €2.07M, comprised of 29.1% salary and 70.9% bonuses, including company stock and options. directly owns 0.69% of the company’s shares, worth CHF6.72M. The average tenure of the management team and the board of directors is 2.1 years and 4 years respectively.
Key information
Juan Gonzalez
Chief executive officer
€2.1m
Total compensation
| CEO salary percentage | 29.1% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.1yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price
Nov 11
PolyPeptide Group (VTX:PPGN) Is Making Moderate Use Of Debt
Oct 21Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)
Sep 16Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?
Jun 19Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce
Mar 14PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price
Mar 13PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 18Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings
Mar 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€29m |
| Mar 31 2024 | n/a | n/a | -€40m |
| Dec 31 2023 | €2m | €604k | -€51m |
Compensation vs Market: Juan's total compensation ($USD2.15M) is above average for companies of similar size in the Swiss market ($USD1.32M).
Compensation vs Earnings: Insufficient data to compare Juan's compensation with company performance.
CEO
Juan Gonzalez (52 yo)
1.8yrs
Tenure
€2,073,967
Compensation
Mr. Juan Jose Gonzalez serves as CEO at PolyPeptide Group AG since April 12, 2023. He had been Chief Executive Officer of Ambu A/S since May 15, 2019 until May 20, 2022 and supports the new CEO (Britt Meel...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.8yrs | €2.07m | 0.69% CHF 6.7m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Director of Global Operations | 2.1yrs | no data | 0.0042% CHF 40.7k | |
| Director of Corporate Finance | no data | no data | no data | |
| Director Global Innovation & Technology | no data | no data | no data | |
| General Counsel & Corporate Secretary | 3.3yrs | no data | no data | |
| Chief Human Resources Officer | 2.7yrs | no data | no data | |
| Head of Technical Department - Braine | no data | no data | no data | |
| Chief Information Security Officer & Global IT Services VC | no data | no data | no data | |
| Head of Internal Audit | no data | no data | no data | |
| Group Controller - Corporate Finance | no data | no data | no data |
2.1yrs
Average Tenure
52yo
Average Age
Experienced Management: PPGN's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & Lead Independent Non-Executive Director | 4yrs | €242.38k | 0.044% CHF 427.8k | |
| Chair of the Board of Directors | 4yrs | €598.15k | 0.068% CHF 661.8k | |
| Independent Non-Executive Director | 4yrs | €218.03k | 0.040% CHF 385.1k | |
| Independent Non-Executive Director | 4yrs | €228.46k | 0.048% CHF 471.3k | |
| Non-Executive Director | 4yrs | €151.15k | 0.071% CHF 693.6k | |
| Non-Executive Director | 4yrs | no data | 0.0097% CHF 94.2k |
4.0yrs
Average Tenure
68.5yo
Average Age
Experienced Board: PPGN's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/07 00:51 |
| End of Day Share Price | 2025/01/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PolyPeptide Group AG is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Markus Mayer | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |